Literature DB >> 20151411

Calculation of the standard binding free energy of sparsomycin to the ribosomal peptidyl-transferase P-site using molecular dynamics simulations with restraining potentials.

Xiaoxia Ge1, Benoît Roux.   

Abstract

The standard (absolute) binding free energy of the antibiotic sparsomycin with the 50S bacteria ribosomal subunit is calculated using molecular dynamics (MD) free energy perturbation (FEP) simulations with restraining potentials developed by Wang et al. [Biophys. J. 91:2798-2814 (2006)]. In the simulation protocol, restraining potentials are activated for the orientational and translational movements of the ligand relative to the binding site when it is decoupled from the binding pocket, and then released once the ligand fully interacts with the rest of the system. A reduced system is simulated to decrease the computational cost of the FEP/MD calculations and the effects of the surrounding atoms are incorporated using the generalized solvent boundary potential (GSBP) method. The loss of conformational freedom of the ligand upon binding is characterized using the potential of mean force (PMF) as a function of the root-mean-square deviation (RMSD) relative to the bound conformation. The number of water molecules in the binding pocket is allowed to fluctuate dynamically in response to the ligand during the calculations by combining FEP/MD with grand canonical Monte Carlo (GCMC) simulations. The calculated binding free energy is about -6 kcal/mol, which is in reasonable agreement with the experimental value. The information gleaned from this study provides new insight on the recognition of ribosome by sparsomycin and highlights the challenges in calculations of absolute binding free energies in these systems. 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20151411     DOI: 10.1002/jmr.996

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  8 in total

1.  Resolving the Ligand-Binding Specificity in c-MYC G-Quadruplex DNA: Absolute Binding Free Energy Calculations and SPR Experiment.

Authors:  Nanjie Deng; Lauren Wickstrom; Piotr Cieplak; Clement Lin; Danzhou Yang
Journal:  J Phys Chem B       Date:  2017-11-09       Impact factor: 2.991

Review 2.  Alchemical free energy methods for drug discovery: progress and challenges.

Authors:  John D Chodera; David L Mobley; Michael R Shirts; Richard W Dixon; Kim Branson; Vijay S Pande
Journal:  Curr Opin Struct Biol       Date:  2011-02-23       Impact factor: 6.809

3.  Computational analysis of the binding specificity of Gleevec to Abl, c-Kit, Lck, and c-Src tyrosine kinases.

Authors:  Yen-Lin Lin; Benoît Roux
Journal:  J Am Chem Soc       Date:  2013-09-20       Impact factor: 15.419

4.  Explaining why Gleevec is a specific and potent inhibitor of Abl kinase.

Authors:  Yen-Lin Lin; Yilin Meng; Wei Jiang; Benoît Roux
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

5.  Correlating protein hot spot surface analysis using ProBiS with simulated free energies of protein-protein interfacial residues.

Authors:  Nejc Carl; Milan Hodošček; Blaž Vehar; Janez Konc; Bernard R Brooks; Dušanka Janežič
Journal:  J Chem Inf Model       Date:  2012-10-08       Impact factor: 4.956

6.  On Restraints in End-Point Protein-Ligand Binding Free Energy Calculations.

Authors:  William M Menzer; Bing Xie; David D L Minh
Journal:  J Comput Chem       Date:  2019-12-10       Impact factor: 3.376

7.  Impact of ribosomal modification on the binding of the antibiotic telithromycin using a combined grand canonical monte carlo/molecular dynamics simulation approach.

Authors:  Meagan C Small; Pedro Lopes; Rodrigo B Andrade; Alexander D Mackerell
Journal:  PLoS Comput Biol       Date:  2013-06-13       Impact factor: 4.475

8.  Computational study of Gleevec and G6G reveals molecular determinants of kinase inhibitor selectivity.

Authors:  Yen-Lin Lin; Yilin Meng; Lei Huang; Benoît Roux
Journal:  J Am Chem Soc       Date:  2014-10-07       Impact factor: 15.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.